<?xml version="1.0" encoding="UTF-8" standalone="yes"?><?xml-stylesheet type="text/xsl" href="/oai-pmh-repository/static/oai2.xsl"?>
<OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd">
    <responseDate>2026-10-16T11:15:18Z</responseDate>
    <request verb="GetRecord" identifier="oai:data.mendeley.com/r37hykxvrs.1" metadataPrefix="oai_dc">https://data.mendeley.com/oai</request>
    <GetRecord>
        <record>
            <header>
                <identifier>oai:data.mendeley.com/r37hykxvrs.1</identifier>
                <datestamp>2025-08-22T20:53:16Z</datestamp>
            </header>
            <metadata><oai_dc:dc xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd" xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
    <dc:creator>Elborei, Mohamed</dc:creator>
    <dc:title>T Regulatory Cells: A Double-Edged Sword in HCC Diagnosis and Prognosis</dc:title>
    <dc:publisher>Mendeley Data</dc:publisher>
    <dc:description> Hepatocellular carcinoma (HCC) stands among the deadliest  cancers worldwide, and part of its resilience lies in its ability  to manipulate the immune system. Within the tumour microenvironment (TME), regulatory T cells (Tregs) characterized  by the markers CD4+CD25+FoxP3+ play a paradoxical role. While  they are vital for maintaining immune balance under normal  conditions, in the context of HCC, they suppress anti-tumour  responses, helping the cancer evade immune detection. Tregs show  significant potential as both diagnostic and prognostic markers. 
However, targeting them for therapy remains a complex endeavour. 
In this piece, I explore how a deeper understanding of Tregs could  reshape the clinical management of HCC, while acknowledging  the challenges posed by their dual roles
</dc:description>
    <dc:subject>Pharmacology</dc:subject>
    <dc:subject>Oncology</dc:subject>
    <dc:subject>Life Sciences</dc:subject>
    <dc:type>Dataset</dc:type>
    <dc:identifier>doi:10.17632/r37hykxvrs.1</dc:identifier>
    <dc:identifier>oai:data.mendeley.com/r37hykxvrs.1</dc:identifier>
    <dc:rights>Creative Commons Attribution 4.0 International</dc:rights>
    <dc:rights>http://creativecommons.org/licenses/by/4.0</dc:rights>
    <dc:relation>https://data.mendeley.com/datasets/r37hykxvrs</dc:relation>
    <dc:date>2025-08-22T20:53:16Z</dc:date>
</oai_dc:dc></metadata>
        </record>
    </GetRecord>
</OAI-PMH>
